Thursday, September 6, 2012

Look Who's Attending the 2nd Annual Clinical Business Expo

Don’t let your company fall behind! There is still time to register for the 2nd Annual Clinical Business Expo, where you and your team will have FULL ACCESS to 5 distinct events. Join top executives from the following companies and learn trend setting best practices from 75+ pharmaceutical and biotech speakers providing 50+ case studies.

Here’s who you’ll meet at the 2nd Annual Clinical Business Expo in Boston:

Amgen *  Bahnson Environmental Specialists * BioStorage Technologies * Cirion Clinical Trial Services * Covidien * DGP Intelsius * Eli Lilly & Company * Eurofins * Fisher BioServices * GlaxoSmithKline * H3 Biomedicine * iCardiac Technologies * JB Therapeutics * Laboratory Corporation of America* Merck & Co * National Cancer Institute * Oregon Health & Science Institute * Parexel International * Pfizer * Quest Diagnostics * Rochester Clinical Research * Seeker Solutions * Thallion Pharmaceuticals * UK Biobank * University of Rochester * Vertex Pharmaceuticals * Vigilant Bioservices * Viracor IBT Laboratories * Virtual Scopics * World Courier * Zalicus *

See the full list here.

Also, don't miss our keynote speakers presenting on:
  • - FDA Update: Leverage the Knowledge of a Complex Pharmaceutical Environment to Transform Drug Development presented by Eric D. Perakslis, PhD, Chief Information Officer and Chief Scientist (Informatics), FDA
  • - Optimize Clinical Trial Logistics: Update from the Transportation Security Administration presented by Gary Lupinacci, Assistant Branch Chief CCSP, Transportation Security Administration
The Clinical Business Expo will take place September 19-20, 2012 with a pre-conference day September 18.  Your registration to gives you access to all 5 events that are a part of the Clinical Business Expo.  As a reader of this blog, when you register to join us and mention code XP1725BLOG, you’ll save 15% off the standard rate! If you have any questions, feel free to contact Jennifer Pereira.

No comments: